Shares of Eli Lilly & Co. LLY sank 0.30% to $797.48 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.16% to 5,836.22 and the Dow Jones Industrial Average DJIA rising 0.86% to 42,297.12. The stock's fall snapped a three-day winning streak.

2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average ( ^DJI 0.78%) had just a 12.9% return, compared to 23.3% for the S&P 500 ( ^GSPC 1.00%) and 28.6% for the Nasdaq Composite.

Palantir stock rebounds, sales of Eli Lilly’s blockbuster GLP-1 medicines miss estimates, and Boeing’s 2024 deliveries fall sharply from a year earlier.

Wall Street mostly rose Tuesday after encouraging inflation data despite Lilly’s drag. The post appeared first on TV News Check. The post Dow Gains 221, Nasdaq Slips 44, S&P 500 Adds 7 originally published on TV News Check.

Drops for Eli Lilly and other influential companies are weighing on U.S. indexes Tuesday, even though most of the market is rising following an encouraging update on inflation.

though drops for Eli Lilly and other influential stocks kept indexes in check. The S&P 500 rose 0.1% as three out of every four stocks in the index climbed. The Dow Jones Industrial Average added ...

Shares of Eli Lilly & Co. LLY slipped 6.59% to $744.91 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.11% to 5,842.91 and the Dow Jones Industrial Average DJIA rising 0.

Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all climbed by double ... to start the new year off right. Eli Lilly(NYSE: LLY) is the maker of one of today's most in-demand treatments: weight loss ...

But the trial showed it achieved an average of 22.7% weight loss after more than a year's treatment, roughly in line with Eli Lilly's Zepbound, which is already available. Morningstar Research ...

Shares of Eli Lilly were taking a 6.9% hit toward a two-month low in recent trading, enough to make them the S&P 500's biggest decliner. The problem is that the drug giant provided fourth-quarter ...

In the latest trading session, Eli Lilly (LLY) closed at $753.98, marking a +1.57% move from the previous day. This move outpaced the S&P 500's daily gain of 0.61%. Meanwhile, the Dow gained 0.3%, and the Nasdaq,

This was the stock's second consecutive day of gains.